Clinical Trials Directory

Trials / Completed

CompletedNCT05438576

Screening for Pregnancy Related Heart Failure in Nigeria

Screening for Peripartum Cardiomyopathies Using Artificial Intelligence (SPEC-AI) in Nigeria

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,232 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

This study will evaluate the effectiveness of an artificial intelligence-enabled ECG (AI-ECG) for cardiomyopathy detection in an obstetric population in Nigeria.

Conditions

Interventions

TypeNameDescription
OTHERDigital stethoscope electrocardiogramDigital stethoscope artificial intelligence enabled electrocardiogram (AI-ECG). An artificial intelligence algorithm which analyses ECG data and generates prediction probabilities for a diagnosis of cardiomyopathy.

Timeline

Start date
2022-08-15
Primary completion
2024-05-15
Completion
2024-05-15
First posted
2022-06-30
Last updated
2025-05-16
Results posted
2025-05-16

Locations

6 sites across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT05438576. Inclusion in this directory is not an endorsement.

Screening for Pregnancy Related Heart Failure in Nigeria (NCT05438576) · Clinical Trials Directory